跳转至内容
Merck
CN
  • Phosphorylation of Farnesoid X Receptor at Serine 154 Links Ligand Activation With Degradation.

Phosphorylation of Farnesoid X Receptor at Serine 154 Links Ligand Activation With Degradation.

Molecular endocrinology (Baltimore, Md.) (2016-08-30)
Takuyu Hashiguchi, Shingo Arakawa, Shogo Takahashi, Frank J Gonzalez, Tatsuya Sueyoshi, Masahiko Negishi
摘要

Comparison of 11 human nuclear receptor amino acid sequences revealed a conserved phosphorylation motif within their DNA-binding domains as an intramolecular signal that regulates proteolytic degradation. Nuclear receptors use this signal to either degrade or proscribe degradation through either the proteasome or nonproteasome pathways. A phosphomimetic farnesoid X receptor (FXR) S154D mutant neither bound to nor trans-activated an FXR-response element-driven reporter gene and was rapidly degraded in COS-1 cells. Ectopically expressed FXR had increased Ser154 phosphorylation in COS-1 cells after ligand treatment, and knock-down of the nuclear vaccinia-related kinase 1 (VRK1) greatly reduced this phosphorylation. FXR was phosphorylated at Ser154 in the nucleus of centrilobular hepatocytes only in ligand-treated mice. Thus, FXR Ser154 phosphorylation is a rheostat for activation and subsequent degradation that controls receptor levels and activity.

材料
货号
品牌
产品描述

Sigma-Aldrich
视黄酸, ≥98% (HPLC), powder
Sigma-Aldrich
GW4064, ≥97% (HPLC)
Sigma-Aldrich
MISSION® esiRNA, targeting human VRK1